drugset / Trial / NCT07072611
Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The goal of this study is to investigate the safety and tolerability of the topical application of SOF-SKN in healthy volunteers. The study will be divided into part 1 and part 2. Part 1, is a single ascending dose (SAD) design, while Part 2 is a multiple ascending dose (MAD) design.
Timeline
- Start
- 2025-07-14
- Primary completion
- 2026-02
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SOF-SKN | Unknown | 0.25 % | Topical |
| Comparator | SOF-SKN | Unknown | 0.5 % | Topical |
| Comparator | SOF-SKN | Unknown | 1 % | Topical |
| Comparator | SOF-SKN | Unknown | 2 % | Topical |